Latest Insider Transactions at Castle Biosciences Inc (CSTL)
This section provides a real-time view of insider transactions for Castle Biosciences Inc (CSTL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CASTLE BIOSCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CASTLE BIOSCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
909
-0.22%
|
$27,270
$30.31 P/Share
|
|
Aug 05
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
649
-0.2%
|
$19,470
$30.31 P/Share
|
|
Aug 04
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,873
-0.59%
|
$146,190
$30.85 P/Share
|
|
Aug 04
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
3,477
-0.53%
|
$104,310
$30.85 P/Share
|
|
Aug 03
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
58
-0.01%
|
$1,740
$30.03 P/Share
|
|
Aug 03
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
42
-0.01%
|
$1,260
$30.03 P/Share
|
|
Aug 02
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
148
-0.04%
|
$3,996
$27.12 P/Share
|
|
Aug 02
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
111
-0.03%
|
$2,997
$27.12 P/Share
|
|
Aug 01
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,977
-1.2%
|
$134,379
$27.44 P/Share
|
|
Aug 01
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
3,723
-1.12%
|
$100,521
$27.44 P/Share
|
|
Aug 01
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,704
-3.13%
|
$208,008
$27.47 P/Share
|
|
Jul 14
2022
|
Ellen Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
440
+50.0%
|
-
|
|
Jul 14
2022
|
Kim Caple Director |
BUY
Exercise of conversion of derivative security
|
Direct |
440
+50.0%
|
-
|
|
Jun 10
2022
|
Mara G. Aspinall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+2.55%
|
-
|
|
Jun 10
2022
|
Daniel Bradbury Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+50.0%
|
-
|
|
Jun 10
2022
|
G Bradley Cole Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+50.0%
|
-
|
|
Jun 10
2022
|
Miles Harrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+50.0%
|
-
|
|
May 12
2022
|
Tiffany Olson Director |
BUY
Open market or private purchase
|
Direct |
1,320
+25.91%
|
$23,760
$18.77 P/Share
|
|
May 12
2022
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+23.85%
|
$12,000
$3.38 P/Share
|
|
May 10
2022
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
486
+50.0%
|
-
|
|
Apr 26
2022
|
Daniel Bradbury Director |
BUY
Grant, award, or other acquisition
|
Indirect |
60,997
+19.85%
|
-
|
|
Apr 26
2022
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
2,230
+50.0%
|
-
|
|
Apr 26
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,311
+9.95%
|
-
|
|
Apr 26
2022
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+5.95%
|
-
|
|
Apr 26
2022
|
Frank Stokes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+11.27%
|
-
|
|
Mar 30
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.76%
|
$398,340
$45.19 P/Share
|
|
Mar 29
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.29%
|
$398,340
$45.41 P/Share
|
|
Mar 15
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.68%
|
$318,672
$36.76 P/Share
|
|
Mar 14
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.64%
|
$336,376
$38.37 P/Share
|
|
Feb 23
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.14%
|
$345,228
$39.28 P/Share
|
|
Feb 22
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.1%
|
$345,228
$39.08 P/Share
|
|
Feb 10
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.54%
|
$398,340
$45.49 P/Share
|
|
Feb 09
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.01%
|
$407,192
$46.56 P/Share
|
|
Jan 24
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
14,631
-3.17%
|
$512,085
$35.44 P/Share
|
|
Jan 20
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
15,604
-3.27%
|
$546,140
$35.3 P/Share
|
|
Jan 18
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
2,470
-0.51%
|
$86,450
$35.25 P/Share
|
|
Jan 10
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Bona fide gift
|
Indirect |
122,181
-100.0%
|
-
|
|
Jan 05
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
16,353
-1.99%
|
$686,826
$42.08 P/Share
|
|
Jan 04
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
16,353
-2.43%
|
$703,179
$43.88 P/Share
|
|
Dec 10
2021
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-8.08%
|
$17,080
$40.52 P/Share
|
|
Dec 10
2021
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+24.89%
|
-
|
|
Dec 10
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,111
-0.91%
|
$84,440
$40.52 P/Share
|
|
Dec 10
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,363
+2.26%
|
-
|
|
Dec 10
2021
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
516
-0.52%
|
$20,640
$40.52 P/Share
|
|
Dec 10
2021
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+1.73%
|
-
|
|
Dec 10
2021
|
Bernhard E. Spiess Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-2.43%
|
$14,640
$40.52 P/Share
|
|
Dec 10
2021
|
Bernhard E. Spiess Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+9.06%
|
-
|
|
Dec 10
2021
|
Frank Stokes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
895
-10.88%
|
$35,800
$40.52 P/Share
|
|
Dec 10
2021
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+19.56%
|
-
|
|
Nov 16
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,409
+4.86%
|
$46,227
$3.72 P/Share
|